Editorial: Complement in nervous system disease

Editorial: Complement in nervous system disease

Bibliographic Details
Main Authors:	Iliana Michailidou, Kees Fluiter, Marina Boziki, Nikolaos Grigoriadis, Frank Baas
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Cellular Neuroscience
Subjects:	complement immunity neuroinflammation neurodegeneration therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fncel.2023.1268023/full

Similar Items

The complement system in neurodegenerative and inflammatory diseases of the central nervous system
by: Luciana Negro-Demontel, et al.
Published: (2024-07-01)

Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody
by: Florine Seidel, et al.
Published: (2023-06-01)

Corrigendum: Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody
by: Florine Seidel, et al.
Published: (2023-08-01)

Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System
by: Sarah M. Carpanini, et al.
Published: (2019-03-01)

VERSATILITY OF THE COMPLEMENT SYSTEM IN NEUROINFLAMMATION, NEURODEGENERATION AND BRAIN HOMEOSTASIS
by: Franca eOrsini, et al.
Published: (2014-11-01)

Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis
by: Iliana Michailidou, et al.
Published: (2018-05-01)

The Complement System in the Central Nervous System: From Neurodevelopment to Neurodegeneration
by: Ying Chen, et al.
Published: (2022-02-01)

Retinal Injury Activates Complement Expression in Müller Cells Leading to Neuroinflammation and Photoreceptor Cell Death
by: Steven J. Tabor, et al.
Published: (2023-06-01)

Oxidative Stress and Neurodegeneration: Interconnected Processes in PolyQ Diseases
by: Ioannis Gkekas, et al.
Published: (2021-09-01)

The Complement System: A Powerful Modulator and Effector of Astrocyte Function in the Healthy and Diseased Central Nervous System
by: Marcela Pekna, et al.
Published: (2021-07-01)

Innate and adaptive immunity in amyotrophic lateral sclerosis: Evidence of complement activation
by: M. Sta, et al.
Published: (2011-06-01)

Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
by: Marta Pajares, et al.
Published: (2020-07-01)

Editorial: Cell-Cell Interactions Controlling Neuronal Functionality in Health and Disease
by: Stefano Angiari, et al.
Published: (2022-06-01)

Editorial: Expert opinions and perspectives in complement: 2022
by: Marcin Okrój, et al.
Published: (2023-07-01)

Editorial: Role of Coagulation Pathways in Neurological Diseases
by: Svetlana Lorenzano, et al.
Published: (2019-07-01)

Profiling Complement System Components in Primary CNS Vasculitis
by: Milani Deb-Chatterji, et al.
Published: (2021-05-01)

Editorial: Central nervous system acting drugs-molecular mechanisms of neuroprotection and neurodegeneration
by: Nesrine S. El Sayed, et al.
Published: (2022-10-01)

Editorial: The complement system in autoimmunity
by: Eveline Y. Wu, et al.
Published: (2022-11-01)

Mass cytometric analysis of the immune cell landscape after traumatic brain injury elucidates the role of complement and complement receptors in neurologic outcomes
by: Amer Toutonji, et al.
Published: (2023-06-01)

Editorial: Complement in the Development and Regeneration of the Nervous System
by: Faith H. Brennan, et al.
Published: (2021-05-01)

Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study
by: Emma L. van der Ende, et al.
Published: (2022-09-01)

Complement-dependent neuroinflammation in spinal cord injury: from pathology to therapeutic implications
by: Hassan Saad, et al.
Published: (2025-05-01)

Beneficial versus Detrimental Effects of Complement–Microglial Interactions in Alzheimer’s Disease
by: Gunel Ayyubova, et al.
Published: (2024-04-01)

Editorial: CNS myeloid cell function in health and disease
by: Christian W. Keller, et al.
Published: (2024-07-01)

Editorial: Multifaceted Interactions Between Immunity and the Diseased Brain
by: Kristen E. Funk, et al.
Published: (2022-06-01)

The future of complement therapeutics
by: Martin Kolev, et al.
Published: (2024-10-01)

Astrocyte- and Neuron-Derived Extracellular Vesicles from Alzheimer’s Disease Patients Effect Complement-Mediated Neurotoxicity
by: Carlos J. Nogueras-Ortiz, et al.
Published: (2020-07-01)

Editorial: Glial cells as an emerging therapeutic target in the pathobiology of central nervous system disorders: friend or foe?
by: Nima Sanadgol
Published: (2023-04-01)

Plant derived bioactive compounds for the treatment of neurodegeneration and neuroimmune disorders associated with the complement system
by: Jeyaparthasarathy Narayanaperumal, et al.
Published: (2024-11-01)

Methadone directly impairs central nervous system cells in vitro
by: Cristian De Gregorio, et al.
Published: (2024-07-01)

S100A4 in the Physiology and Pathology of the Central and Peripheral Nervous System
by: Nadia D’Ambrosi, et al.
Published: (2021-04-01)

Complement peptide C3a receptor 1 promotes optic nerve degeneration in DBA/2J mice
by: Jeffrey M. Harder, et al.
Published: (2020-11-01)

Nerve-Glial antigen 2: unmasking the enigmatic cellular identity in the central nervous system
by: Marta Bottero, et al.
Published: (2024-07-01)

Modulation of the Complement System by Neoplastic Disease of the Central Nervous System
by: Steven K. Yarmoska, et al.
Published: (2021-10-01)

Management of Neuroinflammatory Responses to AAV-Mediated Gene Therapies for Neurodegenerative Diseases
by: Barbara A. Perez, et al.
Published: (2020-02-01)

A Flavonoid on the Brain: Quercetin as a Potential Therapeutic Agent in Central Nervous System Disorders
by: Dagmara Wróbel-Biedrawa, et al.
Published: (2022-04-01)

Editorial: Current challenges in complement diagnostics
by: Per H. Nilsson, et al.
Published: (2023-11-01)

Peripheral inflammation and neurodegeneration; a potential for therapeutic intervention in Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS)
by: Lourdes Hanna, et al.
Published: (2022-05-01)

Complement activation contributes to perioperative neurocognitive disorders in mice
by: Chao Xiong, et al.
Published: (2018-09-01)

Complement Evasion Strategies of Viruses: An Overview
by: Palak Agrawal, et al.
Published: (2017-06-01)